NASDAQ:UROV

Urovant Sciences News Headlines

$16.24
0.00 (0.00 %)
(As of 03/29/2021)
Add
Compare
Today's Range
$16.24
Now: $16.24
$16.24
50-Day Range
$16.17
MA: $16.22
$16.24
52-Week Range
$7.15
Now: $16.24
$16.26
VolumeN/A
Average Volume114,469 shs
Market Capitalization$531.75 million
P/E RatioN/A
Dividend YieldN/A
Beta2.36

Headlines

Urovant Sciences (NASDAQ UROV) News Headlines Today

SourceHeadline
Urovant Sciences Ltd. (NASDAQ:UROV) Short Interest Up 67.3% in MarchUrovant Sciences Ltd. (NASDAQ:UROV) Short Interest Up 67.3% in March
americanbankingnews.com - March 30 at 10:02 AM
Sumitovant Biopharma Completes Acquisition of Urovant SciencesSumitovant Biopharma Completes Acquisition of Urovant Sciences
finance.yahoo.com - March 29 at 8:20 AM
Urovant Sciences (NASDAQ:UROV) Sees Strong Trading VolumeUrovant Sciences (NASDAQ:UROV) Sees Strong Trading Volume
americanbankingnews.com - March 26 at 12:02 PM
Bicycle Therapeutics Ltd. ADRBicycle Therapeutics Ltd. ADR
wsj.com - March 21 at 8:49 AM
Sumitovant Biopharmas Portfolio of Innovative Companies Achieve Significant Clinical and Corporate Milestones in its Third Quarter of OperationSumitovant Biopharma's Portfolio of Innovative Companies Achieve Significant Clinical and Corporate Milestones in its Third Quarter of Operation
marketwatch.com - March 4 at 1:40 PM
Overactive Bladder (OAB) Treatment Market Value Anticipated To Reach US$ 6.5 Billion By 2027: Acumen Research and ConsultingOveractive Bladder (OAB) Treatment Market Value Anticipated To Reach US$ 6.5 Billion By 2027: Acumen Research and Consulting
finance.yahoo.com - March 3 at 10:36 PM
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Urovant Sciences Ltd. (Nasdaq - UROV), Cubic Corporation (NYSE - CUB), CoreLogic, Inc. (NYSE - CLGX)NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Urovant Sciences Ltd. (Nasdaq - UROV), Cubic Corporation (NYSE - CUB), CoreLogic, Inc. (NYSE - CLGX)
finance.yahoo.com - February 13 at 1:10 PM
Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and SafetyUrovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and Safety
bloomberg.com - February 12 at 9:33 AM
ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROVALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV
finance.yahoo.com - January 17 at 8:54 PM
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROVLifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV
finance.yahoo.com - January 3 at 5:59 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – UROV, EIGI, SNCA, CLCTSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – UROV, EIGI, SNCA, CLCT
finance.yahoo.com - December 30 at 12:34 PM
Urovant Sciences Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)Urovant Sciences Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
finance.yahoo.com - December 23 at 5:23 PM
The Week Ahead In Biotech: Light Calendar In Abbreviated Week Features 1 IPO, 2 FDA DecisionsThe Week Ahead In Biotech: Light Calendar In Abbreviated Week Features 1 IPO, 2 FDA Decisions
benzinga.com - December 19 at 7:10 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – EIGI, XLNX, UROV, HDSSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – EIGI, XLNX, UROV, HDS
finance.yahoo.com - December 16 at 12:13 PM
Is Urovant Sciences Ltd. (UROV) A Good Stock To Buy?Is Urovant Sciences Ltd. (UROV) A Good Stock To Buy?
finance.yahoo.com - December 3 at 3:28 AM
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - GV, HDS, UROV, TNAVSHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - GV, HDS, UROV, TNAV
finance.yahoo.com - November 30 at 9:08 PM
WeissLaw LLP Reminds CCR, TCO, UROV, and PTI Shareholders About Its Ongoing InvestigationsWeissLaw LLP Reminds CCR, TCO, UROV, and PTI Shareholders About Its Ongoing Investigations
finance.yahoo.com - November 30 at 9:08 PM
MERGER ALERT – HDS, and UROV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these CompaniesMERGER ALERT – HDS, and UROV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
finance.yahoo.com - November 30 at 4:08 PM
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Foundation Building Materials, Inc. (NYSE: FBM), Urovant Sciences Ltd. (Nasdaq - UROV), HD Supply Holdings, Inc. (Nasdaq - HDS)NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Foundation Building Materials, Inc. (NYSE: FBM), Urovant Sciences Ltd. (Nasdaq - UROV), HD Supply Holdings, Inc. (Nasdaq - HDS)
finance.yahoo.com - November 24 at 7:13 PM
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC MergersSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC Mergers
finance.yahoo.com - November 19 at 6:23 PM
Urovant Sciences Announces Positive Clinical Efficacy and Safety Data from Vibegron EMPOWUR Long Term Extension StudyUrovant Sciences Announces Positive Clinical Efficacy and Safety Data from Vibegron EMPOWUR Long Term Extension Study
finance.yahoo.com - November 19 at 1:22 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Urovant Sciences Ltd. to Sumitovant BiopharmaSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Urovant Sciences Ltd. to Sumitovant Biopharma
finance.yahoo.com - November 18 at 10:20 PM
RM LAW Announces Investigation of Urovant Sciences Ltd.RM LAW Announces Investigation of Urovant Sciences Ltd.
finance.yahoo.com - November 18 at 5:20 PM
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – BSTC, UROV, CXOSHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – BSTC, UROV, CXO
finance.yahoo.com - November 18 at 12:19 PM
UROVANT SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant ...UROVANT SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant ...
businesswire.com - November 18 at 1:36 AM
UROVANT SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant Sciences - UROVUROVANT SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant Sciences - UROV
finance.yahoo.com - November 17 at 8:35 PM
Urovant Sciences: Buyout Price Is Too LowUrovant Sciences: Buyout Price Is Too Low
seekingalpha.com - November 16 at 12:29 PM
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – TNAV, ALSK, NAV, UROVSHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – TNAV, ALSK, NAV, UROV
finance.yahoo.com - November 14 at 1:29 AM
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Urovant Sciences Ltd. BuyoutSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Urovant Sciences Ltd. Buyout
finance.yahoo.com - November 13 at 8:28 PM
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Urovant Sciences Ltd. (Nasdaq - UROV)SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Urovant Sciences Ltd. (Nasdaq - UROV)
finance.yahoo.com - November 13 at 8:28 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Urovant Sciences Ltd. - UROVSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Urovant Sciences Ltd. - UROV
finance.yahoo.com - November 13 at 8:28 PM
Why Urovant Sciences Stock Is Trading Higher TodayWhy Urovant Sciences Stock Is Trading Higher Today
benzinga.com - November 13 at 3:28 PM
Why Urovant Sciences Stock Is Skyrocketing TodayWhy Urovant Sciences Stock Is Skyrocketing Today
nasdaq.com - November 13 at 3:28 PM
UROVANT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of UROV and Encourages Investors to Contact the FirmUROVANT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of UROV and Encourages Investors to Contact the Firm
finance.yahoo.com - November 13 at 3:28 PM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Urovant Sciences Ltd.SHAREHOLDER ALERT: WeissLaw LLP Investigates Urovant Sciences Ltd.
markets.businessinsider.com - November 13 at 3:18 PM
Urovant Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Urovant Sciences Ltd. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – UROVUrovant Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Urovant Sciences Ltd. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – UROV
finance.yahoo.com - November 13 at 10:26 AM
Urovant Sciences Skyrockets After Sale to Largest ShareholderUrovant Sciences Skyrockets After Sale to Largest Shareholder
finance.yahoo.com - November 13 at 10:26 AM
Sumitovant Biopharma to acquire balance shares in Urovant Sciences for $16.25/shareSumitovant Biopharma to acquire balance shares in Urovant Sciences for $16.25/share
seekingalpha.com - November 12 at 5:54 PM
Sumitovant Biopharma and Urovant Sciences Announce Sumitovants Acquisition of Remaining Stake in UrovantSumitovant Biopharma and Urovant Sciences Announce Sumitovant's Acquisition of Remaining Stake in Urovant
finance.yahoo.com - November 12 at 5:54 PM
Urovant Sciences Enters Into Definitive Agreement for Sumitovant Biopharma to Acquire All Outstanding SharesUrovant Sciences Enters Into Definitive Agreement for Sumitovant Biopharma to Acquire All Outstanding Shares
finance.yahoo.com - November 12 at 5:54 PM
Urovant Sciences to Present at the Jefferies Virtual London Healthcare ConferenceUrovant Sciences to Present at the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 10:24 AM
Codexis, Inc. (CDXS) CEO John Nicols on Q3 2020 Results - Earnings Call TranscriptCodexis, Inc. (CDXS) CEO John Nicols on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 9:12 AM
Urovant Sciences (UROV) CEO Jim Robinson on Q2 2020 Results - Earnings Call TranscriptUrovant Sciences' (UROV) CEO Jim Robinson on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - November 2 at 11:37 PM
UROVANT SCIENCES LTD (UROV) Q2 2020 Earnings Call TranscriptUROVANT SCIENCES LTD (UROV) Q2 2020 Earnings Call Transcript
finance.yahoo.com - November 2 at 11:37 PM
Urovant Sciences Reports Second Quarter Fiscal Year 2020 ResultsUrovant Sciences Reports Second Quarter Fiscal Year 2020 Results
finance.yahoo.com - November 2 at 6:36 PM
Urovant Sciences Inks Vibegron U.S. Co-promotion Deal With Sunovion Pharma - Quick FactsUrovant Sciences Inks Vibegron U.S. Co-promotion Deal With Sunovion Pharma - Quick Facts
markets.businessinsider.com - October 7 at 1:00 PM
Urovant Sciences inks co-promotion pact with Sunovion Pharma for VibegronUrovant Sciences inks co-promotion pact with Sunovion Pharma for Vibegron
seekingalpha.com - October 7 at 1:00 PM
Tiny Axonics Modulation Rises To Stock Of The Day On Gains Vs. Giant MedtronicTiny Axonics Modulation Rises To Stock Of The Day On Gains Vs. Giant Medtronic
finance.yahoo.com - September 24 at 2:45 PM
Urovant Sciences: A New Competitor In The Market For Overactive BladderUrovant Sciences: A New Competitor In The Market For Overactive Bladder
seekingalpha.com - September 8 at 12:54 PM
Urovant Sciences to Present at the H.C. Wainwright & Co. Annual Global Investment ConferenceUrovant Sciences to Present at the H.C. Wainwright & Co. Annual Global Investment Conference
finance.yahoo.com - September 8 at 12:54 PM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.